Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Tails that Kill: Characterization of the bactericidal activity of Pseudomonas aeruginosa F-type pyocins
EF 2011-12
Résumé
In the last few decades there has been a rapid emergence of untreatable, bacterial infections that are resistant to multiple drugs. Multi-drug-resistant-Pseudomonas aeruginosa is of specific concern because it is a common cause of infections in immunocompromised and Cystic Fibrosis patients. Following infection, it is very difficult to eliminate this pathogen because it is naturally resistant to most antibiotics and can form aggregates, which allow it to escape the host immune response. Further, multi-drug-resistant strains are emerging rapidly. Since antibiotics are not effective in many Pseudomonas infections, alternative therapies are being explored. A promising alternative is the use of F-type pyocins, which are molecules produced by P. aeruginosa to kill other strains of P. aeruginosa. These particles have been shown to be extremely lethal and are thought to specifically bind to molecules on the surface of P. aeruginosa cells in order to kill them. However, our knowledge about these molecules is very limited, and therefore, in my studies I aim to characterize F-type pyocins. Specifically, I will characterize the killing activities of different F-type pyocins that I have already isolated and investigate all the protein subunits of these molecules that are required for these activities. I will also study what they interact with on the P. aeruginosa cell surface to kill them, and what determines this specificity within the F-type pyocins. In the long run, the knowledge gained from this study will be used to engineer F-type pyocins that are optimized for high purification yields, bactericidal activity and specificity. This work with Pseudomonas will be of high importance to the health of Canadians who live with Cystic Fibrosis, and the knowledge gained will have general applicability for all bacterial infections.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
257539
Name
Saha Senjuti
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Tails that Kill: Characterization of the bactericidal activity of Pseudomonas aeruginosa F-type pyocins
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Antibiotic Resisatnce; Bacterial Biofilms; Bacterial Infection; Bacteriophage; Bacteriophage-Related Therapeutics; Cystic Fibrosis; Genetic Engineering Of Bacteriophage; Lung Infections; Phage-Tail-Like Bacteriocin (Ptlb); Pseudomonas Aeruginosa
Abstract
In the last few decades there has been a rapid emergence of untreatable, bacterial infections that are resistant to multiple drugs. Multi-drug-resistant-Pseudomonas aeruginosa is of specific concern because it is a common cause of infections in immunocompromised and Cystic Fibrosis patients. Following infection, it is very difficult to eliminate this pathogen because it is naturally resistant to most antibiotics and can form aggregates, which allow it to escape the host immune response. Further, multi-drug-resistant strains are emerging rapidly. Since antibiotics are not effective in many Pseudomonas infections, alternative therapies are being explored. A promising alternative is the use of F-type pyocins, which are molecules produced by P. aeruginosa to kill other strains of P. aeruginosa. These particles have been shown to be extremely lethal and are thought to specifically bind to molecules on the surface of P. aeruginosa cells in order to kill them. However, our knowledge about these molecules is very limited, and therefore, in my studies I aim to characterize F-type pyocins. Specifically, I will characterize the killing activities of different F-type pyocins that I have already isolated and investigate all the protein subunits of these molecules that are required for these activities. I will also study what they interact with on the P. aeruginosa cell surface to kill them, and what determines this specificity within the F-type pyocins. In the long run, the knowledge gained from this study will be used to engineer F-type pyocins that are optimized for high purification yields, bactericidal activity and specificity. This work with Pseudomonas will be of high importance to the health of Canadians who live with Cystic Fibrosis, and the knowledge gained will have general applicability for all bacterial infections.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Saha, Senjuti
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~